text:
Cadence Pharmaceuticals: Sentiment is Shifting from Bearish to Bullish (CADX, $4.90)
Posted by Larry Smith on Dec 20, 2012 • (0)
Investment Perspective and Opinion
I continue with my buy recommendation on Cadence Pharmaceuticals.
Cadence introduced its first and only product, the hospital analgesic Ofirmev (intravenous acetaminophen), in January 2011 when the stock was trading at about $7.00. The price climbed steadily and reached about $9.00 in mid-2011. Then sentiment began to shift sharply negative. The sales ramp for Ofirmev was slower than expected leading to downward revisions in sales projections and in June, 2011, Ofirmev's patents were challenged by generic drug companies.
Bearish sentiment took control and the stock drifted steadily and sharply lower to a 2011 yearend close of $4.00 and for most of 2012 has traded in a range of $2.50 to $4.50. The bears argued that sales expectations were still too high and more importantly they predicted that generic competition could begin as early as 2014 in the worst case but almost certainly in 2015 or 2016. This would cause a rapid meltdown in Ofirmev sales. The 90% drop in sales suffered by Plavix in the first year it faced generic competition was sometimes cited as a precedent for what might happen to its Ofirmev.
I believe that consensus opinion is now in the process of changing from bearish to a more bullish tone. I have been writing for some time that the rubber has finally met the road with the Ofirmev launch and as time goes by, I am more convinced. Metrics relating to sales progress has been impressive in 2012 as was shown by results for 3Q, 2012 relative to 2Q, 2012: (1) the sequential increase in sales was 25% helped by a 6% price increase in July, (2) the sequential increase in vials sold was 20%, (3) the number of customers increased 10% to about 3,500, and (4) market share increased in the hospital analgesic market increased from 1.93% to 2.35%. Management has given guidance for 4Q, 2012 sales of $15.9 million to $16.4 million which is an annualized rate of $64 to $66 million; I think this is pretty impressive given that Ofirmev is just in its the eighth quarter of commercialization.
I believe that sales of Ofirmev are on a strong upward trajectory. Sales in 2011 were $11 million. My projections for 2012, 2013, 2014, 2015 and 2016 are $49 million, $101 million, $168 million, $237 million and $332 million. I project that the company will be modestly cash flow positive in 4Q, 2013 on sales $39 million; my model shows that the lowest cash position will be $45 million in 3Q, 2013 and by 4Q, 2014 cash levels will reach $77 million. The company has tax loss carry-forwards that could shield profits through 2016. My untaxed EPS estimates for 2013, 2014, 2015 and 2016 are ($0.34), $0.21, $0.65 and $1.20. My price range target for 2015 is $12 to $16 based on an estimated P/E ratio of 17 to 22 applied to 2016 adjusted EPS of $0.73, which is my estimate of what EPS would be if fully taxed.
My sales, EPS and cash flow estimates for 2013 to 2016 haven't changed much since mid-2012, but they assume no generic competition. Bulls on the stock have been looking for generic competition to begin in 2018 and bears have argued for 2014, 2015 or 2016. All of this uncertainty on the timing of generic competition subdued the reaction to the Ofirmev launch gaining traction, but recently there has been positive news on the patent litigation front. This has caused the stock to move from a close of $3.93 on November 28 to a recent price of $4.90.
On November 28, Cadence announced that it had reached a settlement with Perrigo, one of two generic challengers to Ofirmev's patents. Perrigo essentially agreed to not market a generic version of Ofirmev until December 6, 2020. Later in this article I describe why I think that the second generic challenger, Exela Pharma, may enter into a similar settlement. If so, Ofirmev might not face generics until late 2020. Remember that the bulls were looking for generic completion in 2018 and the bears in 2014, 2015 or 2016. If I am correct, this is a huge positive for Cadence.
The trial on the patent litigation is scheduled to start in May of 2013. If Cadence and Exela are going to settle, I would expect an announcement before then. If the settlement is in line with my thinking, I think the stock might initially over react on the upside, but would settle in at $7 to $8 in 1H, 2013 and then steadily climb toward my 2015 price target of $12 to $16. I want to caution readers that while these numbers appear to be precise, they are just my best guesses and I would urge you to take them with a grain of salt. Still, I think that they may capture the magnitude and trend of the stock price for the next three years.
Patent Settlement with Perrigo
The intellectual property protection (patents) for Ofirmev is not based on composition of matter claims which are the most rigorous of patents. Acetaminophen is a generic drug that has been on the market for more than 60 years as an oral product. Attempts to produce an intravenous formulation repeatedly failed because acetaminophen readily breaks down when exposed to oxygen or water. The key inventions underlying and allowing for the commercialization of Ofirmev were developing a stable formulation and manufacturing process.
Ofirmev is protected by two key patents. The 6,028,222 patent covers the formulation of Ofirmev; with a pediatric extension, it will expire on February 15, 2018. The second is the 6,992,218 patent covering manufacturing of Ofirmev, which expires on December 6, 2021 with the pediatric extension. Bulls have generally believed that the '222 patent was defensible, but believed the '218 was weaker and might be broken. Bears on the stock believe that neither will block generics.
Cadence has consistently maintained that Ofirmev's patents are so broad that it would be very difficult for a generic company to work around. They believe that the formulation patent covers all excipients needed to produce the Ofirmev formulation and in order to bring a generic form of intravenous acetaminophen to market without infringing their patents, a generic company would have to develop an entirely new formulation and manufacturing process. The manufacturing process used by Cadence, to my knowledge, is the only one that has resulted in a stable intravenous formulation of acetaminophen. It seems unlikely that a generic firm has suddenly discovered an entirely new formulation and manufacturing process that doesn't infringe when others have failed for decades. Had anyone else identified a suitable process for stabilizing IV acetaminophen, they would have used that technology to create an intravenous acetaminophen long ago.
In what I regard as extremely positive news, Cadence announced on November 28, 2012 that it had entered into a settlement in which Perrigo has essentially agreed not to market a generic until late 2020. According to the agreement, Perrigo in return has the right of first refusal to negotiate an agreement to market an authorized generic version of Ofirmev in the U.S, if Cadence decides to do so. It also has the non-exclusive right to market a generic in the U.S. under Cadence's NDA, after December 6, 2020 or at such a time as the patents covering Ofirmev are ruled invalid. If this agreement is exercised, Perrigo will purchase product exclusively from Cadence and will pay Cadence for product costs plus an administrative fee, as well as a royalty payment based on the net profits achieved by Perrigo.
Litigation remains ongoing with a second company. There were two firms that filed paragraph IV challenges against Ofirmev: one was Paddock which was subsequently acquired by Perrigo and the second was the privately owned firm Exela Pharma. It is uncertain as to which of these two companies was first to file as the FDA has not yet designated who was the first filer. If it is Perrigo, it will enjoy the 180 days of exclusivity awarded the first filer and Exela would not be able to launch until after Perrigo. While the status of first filer in uncertain, the timing of notifications of a paragraph IV filing to Cadence by the FDA suggests that Exela was first to file. If so, it could still proceed to trial and, if successful go on to launch its generic in perhaps 2015 or 2016.
Regardless who was first to file, this settlement is a very positive development that puts great pressure on Exela to also settle. Exela is a small, privately owned company; I have not seen any financial information on the company but I would think that it has limited financial resources. With Perrigo/ Paddock exiting the stage, Exela is left to carry on the patent battle by itself whereas there would likely have been cost sharing with Perrigo had it not folded its cards. Preparation for the trial could take perhaps $2 to $5 million of legal expenses which might be a pretty significant amount of money for a private company like Exela. Moreover, even if Exela were to win the trial, Cadence would appeal the decision and this would result in still further legal expenses.
It seems to me that the decision of Perrigo to settle with Cadence has significant ramifications. It is a large publicly traded company with huge resources and the infrastructure needed to genericize Ofirmev. Remember that it was Paddock and not Perrigo that filed the paragraph IV challenge. Thus Perrigo's decision is one of a company that is not influenced by the need to justify a previous decision and perhaps can be more objective. It is also a company with great expertise in the field of patent challenges. I can only conclude that Perrigo judged the patents for Ofirmev as being strong and defendable and that there was a good chance of losing if they went to trial. This can't help Exela's confidence in their position.
As I previously mentioned, consensus thinking of bulls on Cadence has been that only the'222 formulation patent expiring in 2018 would offer meaningful protection and generally dismissed the "218 patent expiring in 2021 as being weak. Bears of course thought that neither patent was valid. However, after the Markman hearing last summer that was preparatory to the patent trial scheduled for May 2013, some observers came away feeling that the "218 patent was much stronger than generally believed. The action of Perrigo to settle in a time frame of 2020 supports this thinking. Court cases are always difficult to predict, but having to overturn two strong patents increases the problems for Exela.
Perrigo's actions can be explained by the hypothesis that they judged the patents to be strong and that fighting the legal battle was a poor use of funds, even though it easily has the resources to wage a legal battle. In any event, settling is not such a bad deal for Perrigo. They can forgo the legal expenses, risk of losing the trial and can ultimately rely on Cadence to supply product rather than going through the costly process of building their own manufacturing capacity. It also allows Cadence more time to build the usage of Ofirmev in the marketplace. I estimate that in 2015, Ofirmev could have sales of about $235 million, but the level could increase to $500 million by 2020 substantially increasing the size of the Ofirmev generization opportunity.
The key remaining question is how this will affect Exela in its decision to settle or go to trial. As background, most paragraph IV challenges are resolved through settlements. Given its presumably limited resources, settlement might have been Exela's strategy all along. And the decision of Perrigo to settle has to persuade them that there is a good chance that they could lose and incur sizable legal expenses in going to trial. Some investors have raised the question that Exela might choose to partner or license whatever rights it obtains from this paragraph IV challenge to another company in return for that company helping with the costs of the trial and of course the considerable expense of building manufacturing. However, there might not be a long lineup of potential licensees in the wake of Perrigo's actions and the margins realized by Exela on such a deal could be paper thin.
My best judgment is that Exela will elect to settle and obviously the announcement must be made before the trial scheduled for May 2013 and probably before their lawyers start the costly process of depositions and trial preparations. The next question is if they settle what kind of terms would there be? I think that Cadence and Exela each have something of considerable value to offer the other. If Exela agrees to a settlement that prevents marketing until 2020, it would be huge win for Cadence. Remember that the bears have been saying there will be generics in 2014, 2015 or 2016 and the bulls have been expecting generic competition in 2018. Clarity on the patent situation and two more years of patent life longer than even the bulls were expecting would be a huge win for Cadence; this substantially increases the net present value of future Ofirmev cash flows.
The question is what might there be in this for Exela? First of all, like Cadence, it takes away the uncertainty of the outcome of a trial and associated expenses. Remember also that if Cadence were to lose, it would certainly appeal the decision resulting in still more legal expense. Cadence will not discuss what it might be willing to do for concern that they might be tipping their hand in any negotiations. I have seen in other settlements that the brand name manufacturer has been willing to help a generic company set up production to become a source of product supply for the branded product. This manufacturing would be in place at the time the brand name drug goes generic and along the way, the generic company would be making manufacturing profits. Exela might respond favorably to such an offer from Cadence. I don't propose this as the probable outcome, but it is representative of a settlement that is in the interest of both Cadence and Exela.
Peak Sales Potential for Ofirmev
Ofirmev has significant sales potential in the US. Perfalgan (the brand name of the drug in Europe) has obtained 22% of the European intravenous analgesic market as measured by units. Ofirmev currently has just 2.35% of the US market and is annualizing at about $65 million of sales. At a 22% market share sales would approach $600+ million. There is reason to believe that it could obtain an even higher market share in the US.
The Therapeutic Need Filled by Ofirmev
Ofirmev is initially being marketed as an intravenous formulation for the control of post-operative pain. It can be used before and during an operation and also in recovery if the patients are physically unable to swallow or too nauseous to keep an oral medication down. The current standard of care in this setting is opioids with some usage of NSAIDs. Hospitals are seeking to reduce narcotics use without sacrificing pain relief. One of the major problems with opioids is that they cause constipation. The gating factor for any surgical patient to be discharged is to have a natural bowel movement and Ofirmev through reducing opioid usage can speed the time to the first bowel movement. It can also reduce the mental confusion and grogginess associated with opioids that makes patient care more difficult. NSAIDs are associated with increased bleeding that in the surgical setting can be a problem.
Acetaminophen has a long history of safe and effective use. In its oral form, it is sold as Tylenol and is an ingredient in many other OTC products. The oral is also widely used in the hospitals. There is a need for an intravenous form of acetaminophen in the hospital, but until Ofirmev, none was available. Clinical trials conducted by Cadence showed that it was effective in both relieving pain and reducing the use of opioids. As I did my early field checks, I was struck by how receptive physicians and nurses were to the idea of an intravenous acetaminophen. Continuing checks after the introduction showed satisfaction and heightened enthusiasm for Ofirmev.
Sales Erosion Following Generic Entry May be More Modest than That Seen with Oral Products
Investors have come to expect rapid sales declines when a generic to an oral dosage form comes to market. It is frequently the case that an oral dosage form of a brand name drug loses 90% of its sales volume in 18 months. There is reason to believe that this could be different for an injectable product like Ofirmev.
For another company to manufacture this product, they would need specialized equipment in addition to what they might already have in place for injectable manufacturing. Capacity for injectables is more difficult to find than with solid oral dosage forms because of its greater complexity. Worldwide, the capacity for injectables is dramatically less than for solid dosage forms so that it takes several years for capacity to be built up and for generics to gain significant share. Moreover, the two largest suppliers of intravenous acetaminophen, Baxter (BAX) and Bristol-Myers Squibb (BMY), are barred from providing product to a generic company in the US. Because of these factors, generic penetration post entry of the first generic should be much slower than with solids; there is not likely to be 90% erosion in the first year and one half. As a guess, sales might erode at a 20% to 30% rate over the first three years, which if I am correct, would be through 2023.
Dynamics of the Ofirmev Launch
One of the major negative investment themes in bio/pharma that has developed over the last few years is that the first year for new product launches for the majority of new products has been disappointing. Many hedge funds have now adopted the routine practice of shorting companies with new product launches. There are several factors that have been responsible for this with the increased role of formularies being the most important. In what now seems to be the distant past, there was little that stood between regulatory approval of a new drug and physician prescribing. Formulary access and restraints placed on drug usage even after formulary acceptance now looms as a large boulder.
Ofirmev is sold within a hospital and the continual pressure on hospital revenues and costs has made the formulary a major tool to control money spent on drugs. Before a doctor can prescribe a drug it must first be approved and on formulary. The formularies are usually controlled by pharmacists who often are judged on cost control and not necessarily on therapeutic outcomes. I would hasten to add that I am not saying that formularies are a bad thing; the control of costs is an important aspect of medicine. However, in the zeal to control costs a collateral effect is that it takes a long time to get a product on formulary and additional time to make it available for broad prescribing in the hospital.
There is no set way that a formulary operates, but a typical one might require that a physician or group of physicians sponsor a new drug for formulary inclusion. This triggers off one or a series of committee meetings that try to determine the therapeutic importance of the drug and its cost effectiveness. This process can take some time, usually several months. There seems to be an informal rule emerging at some institutions that a new drug has to be on the market for six months or so in order to gage the potential for side effects before formulary access is considered.
After leaping over the hurdle of gaining formulary access, the drug marketer must then broaden usage throughout the hospital and beyond the original product champion. This is followed by marketing efforts that expand the patient usage and increase doses per patient. This must be in accordance with the product label, of course. All of this adds additional time.
In the case of Ofirmev, concern by pharmacists that Ofirmev would be used in place of oral acetaminophen created a new wrinkle. Most patients in a hospital have an IV line in place and it is easy to give them a vial of Ofirmev, possibly more so than getting them to swallow a pill. Pharmacists feared that instead of giving Tylenol tablets which cost the hospital pennies, many patients would get Ofirmev at $11 per vial and thereby severely impact pharmacy budgets. This was an unexpected, major factor in a slower than expected launch that prompted many investors to judge the launch as disappointing or a failure.
Tagged as Cadence Pharmaceuticals + Categorized as Company Reports


text:
Gavin Webb
Essex, East Anglia
Teaching Location: Ongar, East Anglia, CM5 9NW
Email: Contact Gavin Webb
About Gavin Webb
I started playing drums at the age of 12 at school with drum tutor Phil Aldridge. I then progressed with private tuition with Martin Clapson, who is also teaching with me at Drumbox Studios. After leaving school I played with various function and cabaret bands, backing Bobby Davro and Darren Day. I also played in a Neil Diamond tribute band.
After playing for over 16 years I then decided to improve on my technique and re-studied with Bob Armstrong, who's teaching methods and philosophy opened my playing up to a different feel and level of playing.
Playing and teaching drums has always been my passion and in 2012 I established Drum Box a dedicated studio for teaching and recording Drums.
I still play myself and currently play with The Signatures, a 10 piece northern soul band, Indiana a five piece function band, along with various dep and session work, along with running Catman Boogie and Drum Box.
Martin Clapson has been a Professional drummer for 31 years. He began drumming at the age of 6 and went on to become professional at the age of 15. He studied with Bob Armstrong from the age of 8 to 15. At 15 then went on to study with Max Abrams for 4 years.
He has participated in live studio albums, live videos, live radio and television broadcasts which included Top of the Pops, Children in Need, Terry Wogan, 1994 World Cup Rock Concert in Chicago, Noel Edmonds House Party.
Working also with John Entwhistle of The Who, Dave Stewart of Eurythmics, Jack Bruce of Cream, Tim Rice, John Lee Hooker, Tori Amos, Lee John of Imagination, Suzi Quatro, Love Affair, Robin Trower, Take That.
Theatre work has included Sight reading, backing celebrities, Bob Monkhouse, Larry Grayson, Ruby Murray, Frankie Howard, Kenneth Connors, Clive Dunn, Jim Bowen, Joe Pasqueli.
As a drum tutor for the past 31 years, my most successful pupils have gone on to play professionally and have recorded and toured, the most successful are in their early twenties and have recently been on tours supporting Bryan McFadden and Ocean Colour Scene. He relocated to Dublin in 2006 and became one of Dublin's leading drum tutors.
Our students span from the age of 6 to 66, all are welcome we teach from complete beginners to professionals.
Our fee is £30 per hour but we offer the introductory lesson free.
Drum Lessons in Ongar.

redpajama_set_name: RedPajamaCommonCrawl


text:
Baditude | H-D Iron 883, Honda Phantom vs. Triumph Speedmaster
High Style on a Low Budget
Evans Brasfield, Photography by Evans Brasfield
When it comes to cruisers with attitudes, the largest displacement bikes often steal the spotlight, but it shouldn't always be that way. In many cases, attitude is as much of a factor of styling as it is of out and out performance. So, we decided to gather a trio of bikes from the lighter end of the displacement scale to see what kind of attitude they could bring to the table. All three of our collected players have been around in the same basic form for a couple of years, but both the Harley-Davidson Sportster Iron 883 and Honda Shadow Phantom 750 are relative newcomers within their model lines. The Triumph Speedmaster, on the other hand, is an old favorite (though it received some changes last year).
Our prerequisites for the comparison were simple: Displacement needed to be around 800cc and the styling needed to be minimalist—no gussied-up, deeply valanced fenders here—just the essence of cruiserdom, thank you very much. Had things gone according to plan, all three bikes would be clad in your basic black, but unfortunately, the Speedmaster was only available to us in red. So, when you look at the photos, just picture it as black. It's pretty easy to do.
The Look's the Thing
Stylistically, all three bikes have attitude chops in spades. Starting with the "newest" of the bikes, the Honda Phantom, we can see the current state of blacked-out styling. The Shadow is a collage of blacks and grays with a smattering of chrome thrown into the mix. Then stir in some glossy and matte finishes, and you've got the recipe for a good-looking machine. High notes include the ghost Shadow logo on the tank and the matte finish on the gray fork covers and black headlight shell. The view from the saddle is also attractive, with the instrument cluster wearing a matte gray. While the glossy black hubs and rims coupled with the chromed spokes were pleasing to the eye, the tube tires that those spokes require received mixed reviews.
The Iron 883 also had a nice blend of matte and gloss finishes, only the bodywork is matte and the detail work, semi-gloss. So, the semi-gloss fender rails, shocks and fork sliders complement the larger matte pieces. For 2011, the oil tank and its cap also wear a matte finish. Like Honda, Harley chose to have portions of the Iron's cylinder head stand out as gray from the black engine—plus a touch of chrome from the pushrod tunnels. Similarly, both bikes chose chrome dual exhausts to highlight the engine. The 883 also has chrome stanchions and cool, retro rubber fork covers.
Since the Speedmaster we received was red, we can only assume how it would look in blacked-out mode, but it came pretty close as it was anyway; only the tank, fenders and side covers wore red. Everything else was either chrome or a matte black. Suffice it to say that as a blacked-out bike, the Triumph would lean more heavily on the glossy and chrome treatment that is traditionally found on cruisers, with its instruments, headlight, shocks and peg mounts wearing the shiny stuff.
When you think of cruiser engines, V-twins automatically come to mind. Surprisingly, you'd only be right with two-thirds of these machines. The traditional, 45 degree V-twin Iron 883 leads in the displacement wars with—wait for it—883cc. Just a few ccs behind is the Speedmaster, which charts its own path with an 865cc parallel twin. The Phantom delivers 745cc with its 52 degree V-twin mill. But the incorporation of two cylinders is about as close to unanimity as we'll get here. For example, those cylinders are fed by either two, three or four valves and operated by pushrods or either single- or dual-overhead cams. Or how about this: The final drives are belt, shaft and chain.
The Honda Phantom steps in with a fairly common cruiser power plant configuration. The aforementioned 52 degree V-twin breathes through a single 34mm throttle body and three valves per cylinder, sending power to the rear wheel via a five-speed transmission and a shaft final drive. All the testers noted that, while it was obviously down on power to the larger bikes, the Phantom worked remarkably well. Only when you get out on the Interstate will the Phantom leave you seriously wanting, becoming quite busy. Ironically, the exhaust note on the Phantom was the throatiest and most pleasing of the bunch. The Shadow 750 engine has been around for a long time, and Honda has refined it to a point of seamless operation, making it feel thoroughly modern.
The Speedmaster's engine also feels completely modern while still sporting the iconic profile of the marque's historic vertical twin—a profile Triumph felt was important enough to maintain by hiding fuel injection hardware inside faux carburetors. From the moment you thumb the starter, the engine feels willing—even on cold winter mornings. Get mobile, and this motor immediately feels like the biggest of the bunch, prompting one tester to comment, "It really feels like it gives you a few more ccs than it has." Spot- on fuel delivery combined with a slick-shifting transmission makes for an enjoyable riding experience, no matter what the environment. The easy-to-modulate clutch is a real boon in the stop and go world, too. Many cruiser riders might be surprised at the choice of chain final drive, but despite what belt- and shaft-drive fans say, a chain is easy to maintain on a bike that puts out the power of the Speedmaster.
The Iron 883, on the other hand, garnered a fair amount of criticism. All testers said that the engine felt weak. The popular consensus was that the Motor Company had tried to hide low torque delivery behind a bunch of flywheel weight, thus making it harder to ride. With the bulk of the power in the top of the rev range, the Iron didn't mind if you rapped on it. In fact, it seemed to like it. Still, we expected this time-tested, pushrod- operated, four-valve engine to actually feel more like the biggest one in the test. On the open road, one tester felt that odd gearing choices in top gear made the engine shudder annoyingly, and consequently, he chose to ride it in fourth gear on the highway.
One of the truths about motorcycles is that none of the stuff mentioned above matters at all if the bike isn't fun to ride. Despite its high cool factor, the Phantom was a friendly puppy dog of a motorcycle. The low seat height is a nice touch for a new or shorter rider. The riding position is an easy feet-forward one, and the reach to the bar is roomy without feeling spread out. However, the riding position and the softish suspension conspire to make heel dragging in turns a far too common event.
Still, everything the bike does, it does without drama. Refinement would be the operative word. All of the testers agreed, calling it "the quintessential turn-key bike for a newbie" that "finds a nice balance between looking right and feeling okay." Earlier statements about power deficit aside, being refined doesn't mean the Phantom doesn't perform. It claimed the title of best brakes for the trio. Still, the polished character of the Phantom comes with an $8240 price tag—the second highest in this test.
At the polar opposite of refined lies the Iron 883. Don't get us wrong; that's just part of its personality. The narrow tank and the neither forward nor back peg placement put the rider's lower body in a strangely hunched position. Add in an almost straight-armed reach to the handlebar, and you know that long-distance comfort is not on the ticket. The limited rear suspension travel (1.63 in.) means that you're also going to feel every road irregularity right in the keister. What you do get, though, is a narrow bike with good ground clearance, making the 883 a fun mount for quick maneuvers round town or windy roads. Still, beware the wooden brakes when you're flying low. One tester thought the Iron 883 would make a great entry-level urban warrior. With a few choice modifications, the Iron 883 could shine—a fact helped by the lowest MSRP of the bunch ($7999).
The Triumph Speedmaster provided the most rounded performance of the group. It outperformed the others in every category of the engine department while still delivering a very cruiser-ish character. Overall, the chassis was stable and offered good ground clearance, but with one caveat: in some freeway situations "it hit a certain harmonic with the wheels/chassis/suspension...that put it in a nasty, vision-blurring hobby-horse mode." Other testers commented that, for the most expensive bike in the test ($8299), it had some cheesy brackets. Then there was the issue with it having "The turning radius of a 1965 Chrysler Imperial." However, when it was time to throw a leg over a saddle, the Speedmaster was at the top of every rider's list.
And sometimes, riding is what it's all about. CR
Riding Positions
Will Sheppard
:: 5 ft. 10 in., 175 lb., 33-in. inseam
Being the "Harley Guy" in this group of riders, it really pains me to say that the Sportster just couldn't keep up with the rest! Sure, it's got that 'bad boy' look, and it's lean and agile, but it just doesn't have the power or suspension to fight it out with the other two. The clear winner for me was the Triumph Speedmaster. With its crisp, classic looks and comfortable ergonomics, it really responds when you twist the go-stick—wow, those are some strong readings on the rear-o-meter. The Honda Shadow Phantom is a great bike that will take care of you now, but, three months down the road, the Speedmaster won't leave you wanting for more.
**H-D Sportster Iron 883 *****
**Honda Shadow Phantom *****1/2
**Triumph Speedmaster ******
Steve Mikolas
:: 6 ft., 190 lbs., 32-in. inseam
The Honda is the best beginner/entry-level cruiser in its class. The Shadow gives the rider all the accommodations needed to look tough yet still be quite forgiving when riding; it's the standout, given the platform and controls. It's even got the best brakes of the bunch. That said, with some riding experience under your belt, I'd opt for the Triumph's power and overall performance, which includes the little 'enhancements' the others don't offer. The only good thing I can say about the 883 is that it's a Harley and, unfortunately, it's completely out-gunned in this line-up.
**H-D Iron 883 *****
**Honda Shadow Phantom ******
**Triumph Speedmaster ******1/2
Evans Brasfield
:: 5 ft., 11 in., 170 lb., 32-in. inseam
I'm torn between the looks of the Phantom and the performance of the Speedmaster. Yes, the Honda is a different sort of bike from the Triumph, but stylistically, the different textures of the Phantom really appeal to me. However, I'm all about the ride, so I'd love to graft that mixture of gloss and matte onto the Speedmaster because it is such a fun bike to ride.
H-D Iron 883 **
Honda Shadow Phantom ***1/2


text:
STEEL SOCCER TEAM WANTS CUP GAME HERE
Nat Agar, Brooklyn Wanderer Manager, Trying to Get a Transfer
LOCAL FANS TO SEE CONTEST
That ever influence is being brought to bear to transfer the second round National Cup tie game from Bethlehem to some other grounds is apparent by the overtures already made to the local management to play elsewhere. These influences, it is believed, are agitated by Nat Agar, owner of the Brooklyn Wanderers, who after the draw game at Brooklyn last Sunday, threatened to forfeit rather than play in Bethlehem.
Mr. Agar has until tomorrow morning to make good his threat. The rules of cup competition are emphatic in stating that to scratch a team from cup competition, the management of the team scratching must notify the opponent no less than five days before the scheduled time for the replay. In that event the time limit for Mr. Agar expires at midnight.
There is no penalty of a heavy fine in the event of scratching a team. However, the rule in this respect specifies that in the event of scratching a team without a "satisfactory reason," the club so doing shall be barred from National cup competition the following year. Financial conditions can hardly be accepted as a "satisfactory reason" and rather than be deprived of entering the cup competition next year, it is believed that Mr. Agar will relent in his attitude and Bethlehem fans will witness the first National cup tie game in Bethlehem since the season 1923.
Flattering overtures have been made to the Bethlehem management to play the replay elsewhere than in the Steel City with the financial remuneration by doing so stressed. Executives of the cup committee have entered the field to take the game away from the home grounds, suggesting that the contest be played on Polo Grounds next Saturday afternoon. The purpose, it is stated, is to test the drawing power of the Polo Grounds with two strange teams since it is certain that the Stoneham park will be given consideration for the Eastern semi-final, the Eastern final and the National final.
While the patronage in Bethlehem has been considerably small in contrast to that in other cities in the loop, nevertheless, the local management feels that it is obligated to the several hundred loyals who contribute their mite to keep major league soccer in Bethlehem.
The attitude of the Bethlehem management, relative to transferring the game where it is practically the same as it was when approached in this respect immediately after the two hour one goal draw in Brooklyn on Sunday. And that is that the game will be played in Bethlehem. In spite of the hostile attitude displayed by the Brooklyn management of the local club offered a quite liberal guarantee to have Brooklyn come here. This was not necessary for the home team is obligated to pay only the actual expenses and when these are deducted from the gate receipts the balances is shared between the two clubs on an equal basis.
It has even been suggested that in the event of refusing to transfer the game to a grounds in New York, that it might probably be played in Philadelphia.
This gives rise to the question, why play the replay on a neutral grounds when Bethlehem is entitled to play on home loam? Brooklyn had its fling against the Steelmen on the home grounds in Brooklyn and benefited by the advantages of laying on home loam. That there is an advantage there is no doubt for players are more familiar with the grounds and surroundings when at home than they are on the road. Why then should Bethlehem Steel be deprived of this advantage.
There are greater laurels at state than to survive the second round of the National cup competition. What financial reverses are incurred by playing at home will probably be made up if the Steelmen survive the second round and are then eligible for the semi-final. For after all it is the two final rounds played on neutral grounds that present the most alluring appeal.


text:
Q: proof for a continuous distribution function where a single point has 0 probability of occurring
Here is a proof using the continuity property of probabilities(property which I understand) that for a continuous distribution function, a single point has 0 probability of occurring.
I understand fully this proof until the last line where i'm not completely sure why this follows. Is it because $F_X$ $(a-1/n)$ converges to a as n tends to infinity and hence the expression is equal to 0? (how is $F_x$ being continuous connected to this deduction?)

A: Your guess about the reason is correct.  Remember that a function $f : \mathbb{R} \to \mathbb{R}$ is continuous at a point $a$ if and only if, for every sequence $(x_n)_{n=1}^{\infty}$ such that $\lim_{n\to\infty}x_n = a$, we have $\lim_{n\to\infty}f(x_n)=f(a)$.  In particular, if $F_X$ is continuous, then since $\lim_{n\to\infty}(a- 1/n) = a$, we get $\lim_{n\to\infty}F_X(a-1/n) = F_X(a)$.

redpajama_set_name: RedPajamaStackExchange


Curbside Games – Regina's BEST Party!
The FUN comes right to you!
Our mobile game theater is amazing!
and you'll get to relax! It's the Best Party EVER!
We have the best consoles and games for every age!
No matter the weather, it's always FUN in here!
We bring high-tech gear and a Game Coach to run the party!
Or a park, playground or open field!
Schools, gymnasiums, or any open space. It's year-round FUN!
and your home stays clean! Book your party today!
Mobile Video Game Truck & Laser Tag Parties!
Curbside Games brings the Ultimate Gaming experience right to your front door! Our luxury, limo-style theater on wheels features Four HUGE widescreen high-definition TVs inside, with surround sound and and awesome lighting! It's a multiplayer video gaming heaven! 16 can play at the same time inside our amazing video game truck! We can fit the whole crowd…stadium-style seating allows up to 24 guests inside! We have the greatest games and the best consoles! Summer or Winter, day or night, it's always comfortable in here…we are climate controlled, and with our on-board generator, we're self-powered, too! Our Game Coach will make sure the kids have a blast and the parents get a break! Our amazing mobile video game trailer will blow your guests away! We have the best birthday party idea in all of Regina and southern Saskatchewan! More about our video game truck parties here!
The best laser tag party place in Regina and southern Saskatchewan is the one that comes to you! You get all the fun and excitement of laser tag and paintball combined into one, without having to deal with other parties or people at laser tag centers or the pain and mess that comes with paintball.
Curbside Games Laser Tag is completely mobile, so we come to you! Imagine how your guests' faces will light up when they see the paintball-style course and the true paintball-style guns. We set up the complete course at the location you pick out. Your birthday boy or girl will be the envy of all their friends!
We can even set up indoors! Conference rooms, gymnasiums, warehouses…or outdoors in the woods, an open field, a park…just about anywhere! More about our Laser Tag parties here!
Curbside Games serves the following areas: Avonhurst, Avonlea, Balgonie, Bethune, Briercrest, Bulyea, Claybank, Colfax, Coppersands, Craven, Cupar, Davin, Dlke, Drinkwater, Dummer,Dysart, Edenwold, Edgeley, Estevan, Weyburn, Yorkton, Melville, Findlater, Gray, Hearne, IndianHead, Kendal, Kronau, Lajord, Lang, Lebret, Lewvan, Lipton, Lumsden, Markinch, Mclean, Milestone, Montmartre, Odessa, Parry, Pense, Qu'appelle, Regina, Riceton, Richardson, Rouleau, Sedley, Silton, Sintaluta, Southey, Strasbourg, Truax, Tuxford, Tyvan, Vibank, White City, Wilcox, Yellow Grass, Zehner, Emerald Park, Earl Grey, Deer Valley, Bushell Park, Buena Vista, Belle Plaine, Moose Jaw, Pilot Butte, Stony Beach, and Regina Beach.


text:
Why those men in Lycra may be at risk of their bones crumbling
By Jo Waters For The Daily Mail
When Joe Booth was bending over to pick up a heavy shopping bag, there was a sharp jolt in his lower back.
'I just felt something go and wondered what had happened, but it wasn't initially painful,' recalls Joe, 65, an export sales manager, who lives in Aldringham, Suffolk with his wife, Susan Debnam, 60.
'But when I woke up the next day, the pain in my lower back was so excruciating I struggled to get out of bed.
Joe Booth, 65, was bending over to pick up a heavy shopping bag, there was a sharp jolt in his lower back. These agonising attacks of back pain started in 2014, and it would take him about eight weeks to recover from each, yet there seemed to be no obvious cause
'I'd had several similar episodes before — one occurred when I was just walking a bit faster than usual on a treadmill at the gym,' says the father of three.
These agonising attacks of back pain started in 2014, and it would take him about eight weeks to recover from each, yet there seemed to be no obvious cause.
He took painkillers and sporadically saw a physiotherapist and chiropractor, but after about the eighth episode, the chiropractor advised him to see his GP.
'But my doctor said it was lower back pain, to keep taking painkillers and to come back in six months,' says Joe.
'I just felt something go and wondered what had happened, but it wasn't initially painful,' recalls Joe, 65, an export sales manager, who lives in Aldringham, Suffolk with his wife, Susan Debnam, 60
His symptoms persisted and, eight months later, in January 2016, he decided to pay for a private MRI scan, which revealed four compression fractures, where small bones in his spine had squashed down on themselves rather than break apart.
As a result, he also lost two inches in height, shrinking to 5ft 7in, which was discovered when he was measured by a nurse. And a bone density scan revealed he had osteoporosis — crumbly bones.
'My bone density was so low it was almost off the scale at -5,' says Joe. The threshold for osteoporosis is -2.5.
'I was completely shocked — I'd always been really healthy and, suddenly, I felt betrayed by my body. I wasn't overweight [at 11 stone with a BMI of 22.7, he was in the healthy range] and exercised. I'd never smoked and didn't drink much alcohol.'
Joe is one of an estimated one in five men over 50 who will break a bone due to osteoporosis, where the bones become thin and porous and start to fracture, sometimes spontaneously or after only minor low-impact falls.
Common sites for fractures include the hips, wrists and spine. Three million people in the UK have osteoporosis, and the Royal Osteoporosis Society estimates that 680,000 of them are men.
Bone loss is a normal part of ageing for both sexes, but is most commonly diagnosed in women after the menopause, when levels of the bone-building sex hormone oestrogen fall dramatically, speeding up bone density loss.
This is why it was believed that osteoporosis is less common in men. But new research suggests that more men could be affected than previously thought.
A study published in The Journal Of The American Osteopathic Association last month found that 28 per cent of men and 26 per cent of women, showed signs of osteopenia, the precursor to osteoporosis, where bone density is reduced.
In the U.S. study, researchers analysed the bone mineral density levels of 173 healthy adults between 35 and 50.
Bone loss is a normal part of ageing for both sexes, but is most commonly diagnosed in women after the menopause, when levels of the bone-building sex hormone oestrogen fall dramatically, speeding up bone density loss [File photo]
The study's author, Dr Martha Ann Bass, associate professor of health, exercise science and recreation management at the University of Mississippi, says their findings highlight the elevated risk of crumbling bones in younger men. 'I think this is a more prevalent issue than anyone expected,' she says.
Although the men in the study had good exercise habits, the majority reported cycling as their exercise of choice. Bone is living tissue and gets stronger with use — this depends on weight-bearing exercise such as running: cycling is not weight bearing.
Sam Woodfield's story epitomises the risks. An elite cyclist, who rides with the ActiveEdge Race Team, he was diagnosed with osteoporosis in his hip and spine two years ago.
At the time, the 28-year-old, who is single and lives in Oundle, Northamptonshire, had been training for up to 22 hours a week and had severely restricted his calories for two years (bone health also depends on a good intake of calcium and vitamin D).
Eating a lime ice pop in the sun can leave your child with... Doctors could use SCORPION venom to fight human infections...
'As a racing cyclist, there's a some pressure to keep your weight down so you can go faster,' says Sam. 'I felt I was overweight for the sport.'
At that point he weighed 14½st (92kg) and, at 6ft 3in, had a BMI of 25.2, which made him technically slightly overweight.
'I tried to work off the extra pounds by training hard and restricting my calories,' he adds.
By October 2016, his weight had dropped to 11st 3lb (72kg). Sam saw a specialist sports dietitian, who warned him he was putting his health — and his bones — at risk. 'I started to eat more, but it still wasn't enough to fuel the exercise I was doing. Looking back, I had an eating disorder.'
In November 2017, he had a bone scan. 'I was horrified to be told I had osteoporosis in my spine and hip, and osteopenia through the rest of my skeleton,' recalls Sam.
'I basically had the bones of 75-year-old. It was the wake-up call that I needed.'
He's since moderated his training and is eating well. He now weighs 11st 10lb (76kg), with a BMI of 20.5, which is back in the healthy range. And his bone density has improved from the osteoporosis range to osteopenia.
'My case is an extreme one,' says Sam, 'but it shows that you're never too young to be thinking about your bone health.'
Sam Woodfield's story epitomises the risks. An elite cyclist, who rides with the ActiveEdge Race Team, he was diagnosed with osteoporosis in his hip and spine two years ago
Although the Mississippi study was small, it highlights that men are at risk, says Dr Rod Hughes, a consultant rheumatologist at St Peter's Hospital in Chertsey, Surrey, and medical adviser for the North West Surrey Royal Osteoporosis Society.
'There are a number of factors which might be putting younger men at risk, including increasing consumption of carbonated drinks [which are linked to bone mineral loss], drinking less milk and children being more sedentary in the crucial bone-building years, when weight-bearing exercise is particularly important,' says Dr Hughes.
'Vitamin D deficiency is also a factor, which can be caused by excessive use of total sun block cream — in Australia there has been an outbreak of rickets in children because of this,' he adds.
Other risk factors include low levels of the bone-protective hormone testosterone, or malabsorption of minerals due to ulcerative colitis, Crohn's or coeliac diseases.
Drinking excess alcohol is considered another risk factor, as is smoking heavily.
'Family history may also play a role in both men and women in osteoporosis, as the genes that carry a risk of the disease deal with bone metabolism and metabolism of vitamin D.'
The problem is that osteoporosis in men may not be on doctors' radar, suggests Dr Panos Gikas, a consultant orthopaedic surgeon at the Royal National Orthopaedic Hospital in Stanmore, Middlesex, and The Lister Hospital, a private clinic in Chelsea.
'Clinicians don't always have the same index of suspicion for the disease when they are treating men, so many go undiagnosed,' says Dr Gikas.
'If a man over 50 has a fracture from a low-impact fall — from standing height or below — then they should have a bone scan.'
Tests revealed Joe Booth's thinning bones were caused by undiagnosed coeliac disease, an autoimmune condition, where the body reacts to the gluten in wheat, barley and rye, damaging the lining of the gut, so calcium, and vitamin D can't be absorbed. He's now switched to a gluten-free diet to allow his gut to heal.
'I also see a specialist physiotherapist for exercises to strengthen muscles that support my spine,' says Joe
He was also given a six-monthly denosumab (brand name, Prolia) injection to slow down bone loss, calcium and vitamin D supplements and daily injections of teriparatide (Forsteo), a type of drug that builds bone density.
Joe has had no more fractures since he fractured a rib walking upstairs in April 2017, but still needs weight-bearing exercise to maintain bone density.
He says: 'I'm determined to stay positive and not be an invalid. I walk as much as possible and do tai chi to improve my balance and prevent more falls.'
For more information visit theros.org.uk
Ask Dr Google
This week: What is ADHD?
Dr Google said: A wealth of web pages describe Attention Deficit Hyperactivity Disorder as the 'most commonly diagnosed mental disorder of children', others claim ADHD is not a 'real disease' or is due to bad parenting.
The Expert: 'ADHD is recognised as a neurodevelopmental disorder, rather than a behavioural one. It is not caused by poor parenting or diet, though neither will help,' said Dr Tony Lloyd, a psychologist and chief executive of the ADHD Foundation.
'Research shows people with ADHD have structural and functional differences in the brain. The key symptoms are poor concentration, hyperactivity and impulsivity.
'Many people with ADHD also suffer from mental health problems — as many as one in five attempt suicide and 40 per cent will have chronic anxiety.'
Royal Osteoporosis Society | Osteoporosis Charity UK | Better bone health for everybody


text:
Our Sound
Shows to watch for:
← Young, local, classical musicians home for holiday concerts
Youth passion drives theatre project →
Dance project unites family's music
Jennifer and Jason Hunter left behind jazz and opera careers in Boston to raise their children Gabriel, 1, Serena, 3, and Maya, 7, in Jason's home town of Kincardine. Hunter leads a jazz combo, including Jennifer on vocals, for the Sheila Milne Celtic Dancers of Owen Sound Christmas dance performances Dec. 18 and 18 at The Roxy in Owen Sound. BILL HENRY/The Sun Times.
BILL HENRY
Sun Times staff
After 10 years in Boston, Jason and Jennifer Hunter's careers were well established.
Jason was playing jazz with the people he wanted to work with. Jennifer was singing in operas. After years of study, they were both finally making a living in music.
But with a year-old daughter then, a troubled American political climate and an unexpected $15,000 annual fee for the school they chose, the couple was at a crossroads.
So in 2006, they chose lifestyle ahead of music careers and moved to Jason's home town of Kincardine to raise Maya, seven, and now Serena, three and Gabriel, one.
It was "the right decision," Jennifer said recently.
If not for that move, the highly-schooled jazz saxophone player and classically-trained singer of opera and African American spiritual music would never have collaborated, as they've done for "So This Is Christmas" with The Celtic Dance Company of Owen Sound.
Jason has assembled a jazz combo for shows Dec. 18 and 19 at The Roxy Theatre, featuring longtime Owen Sound jazz man Don Buchanan, bassist Tyler Wagler and others, with Jennifer singing some classic 1960s Christmas standards from Ella Fitzgerald repertoire.
Jason said he'd thought for years that his wife's voice would suit that music, but in Boston, their careers never overlapped.
"It really is the first time we're working together," Hunter said, during a recent rehearsal at Sheila Milne's Owen Sound dance studio. The couple's daughters are dance students, and part of the Christmas dance and music production.
"Had we been still in Boston, I don't think something like this would have happened," Jennifer said. "We were in two completely different camps as far as the music we were performing. I don't think we even ever talked about performing together. Not until we moved up here."
Jason grew up in Kincardine, where as a high school student under music teacher Ian Burbidge's leadership, he soon "wiggled my way" into playing big band jazz with both the Stardust Big Band and the Lighthouse Swing Band.
He pursued the big band jazz interest for four years at McGill in Montreal, known then for its focus on big band and 1960s bebop and post bebop styles. Hunter went next to Boston's New England Conservatory of Music for a Masters of jazz performance. He wanted to expand into more contemporary jazz styles and explore modern improvisational music.
During 10 years gigging Boston and New York he worked with jazz luminaries like Bob Brookmeyer, George Garzone, Jimmy Heath, Joe Lovano and Kenny Wheeler. He was a member of George Russell's Living Time Orchestra, the Artie Shaw Orchestra, played on on dozens of recordings, most notably with Guaranteed Swahili, Dead Cat Bounce, Charlie Kohlhase, Kakalla, Patrice Williamson, and on the Boston Modern Orchestra Project's Journey into Jazz.
In Canada, he has performed with Michael Bublé, the Temptations, Barry Elmes, Lorne Lofsky, singer-songwriter Kate Schutt, and Sploink, the Noodle Factory Jazz Orchestra, and the Stardust Big Band.
"I was looking for something a little bit more contemporary, a little bit freer, a little bit more influenced by music that had happened since" the 1960s jazz era he studied at McGill.
Hunter said the most important thing about his time at the New England Conservatory of Music was meeting his future wife there.
Raised in a musical family Indianapolis, Indiana, Jennifer studied voice at Oberlin Conservatory in Ohio, then pursued her masters at The New England Conservatory in vocal performance and vocal pedagogy
"At graduate school, I did a lot of soul searching and finding my voice and discovering where my passion for music is and what I really enjoy singing," she said.
That led the soprano to a position with the prestigious National Spiritual Ensemble, a small group which toured the U.S. specializing in African American spiritual and gospel music.
"It was a tremendous learning experience," Hunter said. "Everyone had the opportunity to greatly express themselves artistically and musically. It was a real growing experience and a real soul searching experience, and being African American myself, I felt a real connection, and I still do, to that music.
She was a featured soloist for Boston's Black Nativity under the direction of John Ross, and soprano soloist for the Cantata Singers Chamber Series under the direction of Kayo Iwama.
"My training, my background and my education is in classical music. It's in opera. And it's with those skills that I enjoy singing all kinds of music, but particularly the African American music," Hunter said.
Both parents said the move to Kincardine has not robbed them of music, but instead has provided also a rich, ideal lifestyle for raising a family.
"It was a tough decision," Jason said.
"Musically, I'm not singing with any operas," Jennifer said. "But I'm enjoying myself and I'm expressing myself and I have a wonderful family and I think as the kids grow and get older, hopefully I can do more music in the community," Jennifer said.,
At first Jason, who now works at Bruce Power as a nuclear operator, remained connected to the Boston and New York jazz scene, with occasional return trips for gigs. With three kids now, he keeps closer to home and has been playing with the local jazz groups Noodle Factory, led by his former teacher Ian Burbidge, and Sploink, another group with Don Buchanan, playing original jazz music.
"There are people around and there are places to play," Hunter said.
"It's a change but it certainly hasn't meant my dreams of playing music are squashed or anything like that. They've just changed. The perspective is a little different and I have different goals. Getting the music ready for this show is as much of a challenge as pretty much anything else I've done.
With "So This is Christmas," it's his first time leading a jazz group for dance music, and the first time Sheila Milne's classical ballet, modern dance and Highland students have performed with jazz music.
Bassist Tyler Wagler, guitarist Andy Harasymczuk, and drummer Michael Sloski, are part of the group, while Jamie Smith will also sing.
Daniel Carr, a former Milne student who recently won the adult world Highland dance competition in Scotland will perform, as will Anne Thomson, who is an Ontario Champion, Canadian Champion and North American Champion and has been been a runner-up at the world championships in Scotland.
Heather Dixon and dancers from her Dixon's Dance and Fitness Studio are also part of the show, at The Roxy Saturday, Dec. 18 at 8 p.m. and Sunday Dec. 19 at 2 p.m. Tickets are $20 and $18 for seniors and students, available at the Roxy box office.
(Bill Henry is a Sun Times news reporter and photographer. Our Sound runs Fridays. bhenry@thesuntimes.ca)
Filed under Our Sound feature
Owen Sound Sun Times
Owen Sound Sun Times on Facebook
Our Sound feature
Personality profile
Our Sound · Bill Henry's Sun Times music columns and photographs about the Grey-Bruce music community.


The Milpitas Planning Commission will consider approving a 150-room extended-stay hotel off Interstate 880 at its April 11 meeting, an official said Tuesday.
The Hilton Home2 Suites, proposed by Amrat Patel of Livermore-based Amdon Investments, would be built at 1301 California Circle.
The developer is seeking an exception to the city's height limit for the planned five-story building, as well as an exception for a greater floor-area ratio than the property is zoned for.
The project would also subdivide the 6.34-acre property into two parcels, with the hotel to go up on a 3.35-acre parcel. The other parcel would be left vacant for now, but could potentially be used for another hotel development in the future, according to the report. The building would be 21,988 square feet and rise 62.5 feet, with a 72-foot-tall tower element.
The developer demolished some unoccupied industrial buildings, leaving the property vacant.
If the Planning Commission approves it, the project would then need to get the City Council's OK, which Milpitas Planning Manager Jessica Garner said could happen in early May.
A city staff says the area, zoned for use as an industrial park, does accommodate hotels with conditional use permits.
To the south of the site where the Home2 Suites is planned, two other hotels are under construction, according to a staff report. Both received approval to be built taller than the proposed hotel.
The proposed hotel is "compatible with the identity of the Dixon Landing Business Park area, which is becoming a lodging hub for visitors of the South Bay," the report adds.
The project would convert a vacant lot into "a higher and better use that generates revenue for the city via the Transit Occupancy Tax, sales and property tax," the report says. City staff is recommending the commission approve the hotel.
The commission was set to discuss the project at its March 28 meeting, but continued it because some details about the project were missing from the advance public notices.


Coal India Ltd. operates as mining company. It engages in the production and sale of coal. The company was founded in November 1975 and is headquartered in Kolkata, India.
Coal India official: need for coal export policy Monday, 17 September 2018 12:06 A senior Coal India official has said that the state company requires a policy on coal exports as a prerequisite to completing commercial export contracts.
Coal India officials are of the view that the shortage of coal in the power plants can be eased once hydel power production picks up in the country. After Air India failure, govt now hoping to offload stake in Coal India. 9.46 pm | 18 Jun 2018 | Bloomberg.
Chapter V (Industries) - Dhanbad District Of Jharkhand. The rich variety of coal by products from these coke plants has provided the ... The famous Jharia Coalfield in the district is the richest treasure-house of India's.
• Coal India was formed as PSU in Nov 1975. • During 1975-91 massive investment by Govt. helped to achieve a growth rate of 5.3% • 'Coal at any cost' continued to dominate the 9 investment strategy during this period.
На сайте публикуются материалы о данных стран мира: экономических, демографических, географических, рейтинги техники, технические данные, уникальные объекты в природе, выдающиеся строения.
Также он владеет пакетом акций в компаниях Coal India и ONGC. Состояние Мукеша Амбани оценивается в 21,2 миллиарда долларов. Находится на девятой строчке в списке самых богатых людей мира 2015. 8.
forbes. Проверено 21 января 2008. Архивировано 3 марта 2012 года. ↑ Time to say hi to Tata's dream car. The Times of India. Архивировано 3 марта 2012 года. ↑ Bajaj Auto car by 2009. dancewithshadows. Проверено 21 января 2008.
За ними следуют, Coal India, Pemex, российская угольная промышленность, Royal Dutch Shell PLC, China National Petroleum Corp. Украина в рейтинге заняла 40 место.
in 2000 to form a new company to market both companies' beer, with a plan to even- ... make Forbes Asia Fab 50 list, which is dominated by Chinese and Indian firms. The list recognises top public ... biggest since state-run Coal India raised US$3.5 billion in an initial pub- lic offering in 2010.
An Electric Bus That Recharges While You Step Inside. . Read it ... Coal India is in Sibanye Gold is the" ... (Half) Dead - Forbes" See more. Urban Landscape Landscape Design Path Design Landscape Architecture Architecture Design Queen Public Space Design Pedestrian Street Furniture.
Current Affairs ,international Affairs,state news ,national news,Summits ,Awards of month of April,may june,july . INTERNATIONAL Victory for Suu Kyi The opposition leader of National League for Democracy (NLD) Aung San Suu Kyi had won the election held in Myanmar on 1 April 2012 for 45 parliament seats and NLD won 43 seats.


text:
Runtown Biograhy, Net Worth, Age and Career
Posted by Fadehan Emmanuel September 1, 2020
Jay Z Net Worth and Biography
Douglas Jack Agu (born August 19, 1989), professionally known as Runtown, is a Nigerian singer, songwriter, artist, and producer.
Runtown net worth is estimated to be $2 million.
In this write-up, we will bring you everything you would love to know from Runtown net worth, biography, musical career, endorsement deals, awards, and so on.
Runtown Profile
Runtown Biography
Runtown Early Life
Runtown Record Label
Runtown Songs & Albums
Runtown Personal Life
Runtown Houses and Cars
Runtown Endorsements
Runtown Net worth
Birth name: Douglas Jack Agu
Origin: Enugu State, Nigeria
Genres: Afro-fusion, R&B, hip hop, reggae
Occupation(s): Songwriter, singer, producer
Instruments: Vocals
Labels: Soundgod Music Group
Douglas Jack Agu, formally known as Runtown, he is a Nigerian singer, songwriter, artist, stage artist, fashion enthusiast, and producer. He is a famous musician who started his musical career in 2007, after releasing his first single Runtown.
So far, he has had big success in his career. He has fans all over the country and the world.
Runtown was born August 19, 1989, in Enugu, but raised partly in Abuja and Lagos, where he completed his primary education. After his father died, he moved to Abuja with his mother, who was a health worker.
In 2014, he released "Gallardo," a song that features Davido's voice, and was released as the first single from his debut studio album Ghetto University. Gallardo was critically acclaimed, and the music won "Best Collaboration of the Year" at the 2014 Nigeria Entertainment Awards.
On November 23, 2015, Runtown released his debut studio album titled Ghetto University via MTN Music Plus through Eric Many Entertainment (his former label). The album streams generated over £35million on the music portal, earning this spot on the '5 Most Popular Artists' list.
On November 4, 2016, Runtown released another hit single titled "Mad Over You," which peaked at No. 38 on Billboard's Top Twitter Tracks list. "Mad Over You" is widely broadcast in various media in Nigeria and African countries. Runtown revealed in one of his recent interviews that an African beauty inspired the song.
Runtown's contract with Eric Manny Entertainment elapsed in June 2018. He went on to found his label, Soundgod Music Group.
We have handpicked a few songs from his numerous.
Mad over You
Bend Down Pause
Oh Oh Oh (Lucie) – Popcaan Remix
Body Riddim
International Badman Killa
Lagos To Kampala
1Walahi
The Banger
Gallardo (feat. Davido)
Ghetto university
Tradition EP
Soundgod Fest Vol. 1
Runtown Hits Vol. 1
Urban Heartbeats Vol. 71
Unlike most other artists, Runtown is married to his exemplary wife Selena Leath, they both met in 2015 and have developed a healthy relationship, and together they have a son called Zamar.
Besides being a singer/producer, Runtown is also interested in the world of fashion, currently attending a fashion school in the United States.
Runtown has produced 10 music videos, 1 studio album and 17 singles, and has won numerous awards and accolades for himself, the most significant of which are listed below.
2014 Best Collaboration of the Year, 'Gallardo' Nigeria Entertainment Awards
2017 African Artist of the Year, Ghana Music Award
Best Collaboration of the Year 2017, Soundcity Music MVP Awards
Viewer Selection, Soundcity Music MVP Awards, 2017
Artist of the Year Award, Ghana-Naija Showbiz Awards, 2017
Runtown is one of these Nigerian celebrities who enjoy the comfort and an expensive lifestyle; he has a well-furnished house and a fleet of shiny, expensive cars in his garage.
As a birthday present, he bought a custom Mercedes Benz G-Wagon, which cost up to 35 million naira in 2017. He also purchased a brand new Lamborghini Gallardo, which cost him 150 million naira, making him the first Nigerian celebrity to buy a new Lamborghini Gallardo car.
In 2015, RunTown secured a multimillion naira endorsement deal with the world's leading sportswear manufacturers Adidas. He also has several contracts with telecommunications companies in Nigeria who use his songs for tunes.
Runtown has also had its share of controversy. In 2014, the media learned that Davido's famous song "Aye" was initially owned by Runtown and that Davido was likely to infringe copyright. Over time, however, Runtown went public and cleared the air, although vestiges of the controversy still exist today.
In mid-2016, he began to break up with Eric Manny Entertainment. The sticker is said to have received a court ruling banning her from recording songs and performing at events.
He stated that he is even more accustomed to performing the mentioned activities without the knowledge and with the permission of the publishing house.
Runtown denied the allegations against him in its response and subsequently dropped the label. According to him, his existence there posed a significant threat to his life and his musical career.
In 2014, he won Best Collaboration of the Year at the Nigeria Entertainment Awards for his song "Gallardo," which starred Davido. The same year, Runtown was nominated for a "Next Rated Act" at the Headies Awards.
In 2015, he also won a nomination for "Best Pop Artist" at the Nigeria Entertainment Awards; the same year, Runtown was nominated for the City People Entertainment Awards as "Artist of the Year."
Speaking of runtown net worth: Runtown is currently one of the wealthiest and most influential artists in the Nigerian entertainment scene, valued at $ 2 million.
Also to making money from his music, Runtown has several deals to approve, most notably his contract with MTN and Adidas, which is worth millions of naira.
Share on Facebook Share on Twitter Share on Pinterest Share on WhatsApp Share on WhatsApp Share on Linkedin Share on Reddit Share on Telegram
Previous Article Abovi Ugboma (Bovi): Biography, Net Worth, Age, Career
Next Article Yemi Alade Biography and Net Worth
Who Is Sinach?
Prince Ned Nwoko: Biography and Net Worth
Tonto Dikeh: Biography and Net Worth
Chimamanda Ngozi Adichie: Biography and Net worth
Folorunsho Alakija Biography and Net Worth
Olusegun Obasanjo Biography and Net Worth
Beyoncé Biography and Net Worth
Naira Marley Biography and Net Worth
Floyd Mayweather Net Worth and Biography
Wiz Khalifa Net Worth and Biography
Osinachi Joseph popularly known by her stage name Sinach is an Award-winning ...
Posted by Emmanuel Ekokotu December 19, 2020
Who Is Cynthia Morgan?
Cynthia Morgan (now known as Madrina), is a Nigerian born singer, songwriter and ...
Who Is Seyi Shay?
Deborah Oluwaseyi Joshua, best known as Seyi Shay, is a Nigerian singer-songwriter, ...
Who Is Sofia Reyes?
Sofia Reyes is a Mexican singer, songwriter and actress, who became famous ...
Stonebwoy – Biography and Net Worth
Stonebwoy is a multi-award-winning musician, who hails from the Volta Region of ...
Posted by Emmanuel Ekokotu December 7, 2020
Vanessa Mdee – Biography and Net Worth
Vanessa is arguably one of Tanzania's finest international export. The telnet d ...


CARRIE UNDERWOOD ANNOUNCES THE CRY PRETTY TOUR UK.
She will be joined on the UK tour by special guests, The Shires, the UK's best-selling country act of all time.
Underwood's latest album Cry Pretty debuted at No. 1 on both the Billboard 200 and Top Country Album Charts and was the biggest all-genre debut by a female in 2018. The debut earned Underwood a place in music history as the only woman to land four country albums at the top of the all-genre Billboard 200 chart, as well as the first female country act to top the Billboard Artist 100 Chart. The critically-acclaimed, gold-certified album, was the best-selling Country album debut of 2018, as well as the biggest Country album debut since 2015 and the biggest female Country album debut since 2012. The album's lead single and title track, "Cry Pretty" was released in April 2018 and debuted as the #1 song in the U.S. all-genres chart. The song also topped download charts in 38 countries around the world and amassed over 3.5 billion social impressions across 66 countries during its first week. North American tour, The Cry Pretty Tour 360, will kick off on May 1 in Greensboro, NC, and will play 55 arenas across the U.S. and Canada. She will be joined by special guests Maddie & Tae and Runaway June for the North American tour, which is sponsored by CALIA and promoted by AEG Presents. For more information visit www.carrieunderwoodofficial.com.
Tickets for the UK shows will go on sale Thursday, March 7 via www.gigsandtours.com and www.ticketmaster.co.uk. As she has done for her North American shows, Underwood has arranged for a donation from each ticket sold for The Cry Pretty Tour UK to be contributed to Danita's Children, which provides a safe haven for abandoned and vulnerable children in Haiti, while encouraging families to stay together through their education and malnutrition programs.
ACM AWARDS NOMINATIONS HAVE BEEN ANNOUNCED, AND CHRIS STAPLETON IS LEADING THE LIST.
The nominations for this year's ACM Awards have been announced and the reigning Male Artist of the Year Chris Stapleton leads the list (ties with Dan + Shay) with six nods, including Entertainer of the Year. He is also nominated twice, as both artist and producer, for Album of the Year for From A Room: Volume 2, which he won last year for From A Room: Volume 1. Plus, he's nominated for Song of the Year twice, as both artist and songwriter, for "Broken Halos." He's also up for Male Artist of the Year. He's won numerous awards over the past few years, and while he's grateful for every single trophy he takes home, he has a special affinity for the Album categories.
Kacey Musgraves earned five nominations in three categories, including a nod for Female Artist of the Year. Additionally, she is nominated in the Album of the Year Category twice, as both artist and producer, for Golden Hour, as well as in the Song of the Year category twice, as both artist and songwriter, for "Space Cowboy." Kacey, who took home four Grammy Awards a couple of weeks ago, most recently won an ACM in 2016 in the Video of the Year category for "Forever Country" and previously won in the Album of the Year category in 2013 for Same Trailer Different Park.
Dierks Bentley received four nominations, including his fourth nod for Album of the Year for The Mountain. Dierks is also nominated for "Burning Man" (featuring Brothers Osborne) in both the Music Event of the Year category and Video of the Year category. He is also nominated for Male Artist of the Year. If he were to win for Video of the Year this year, it would mark his third win in this category.
Maddie & Tae are looking forward to being in Vegas for this year's ACM Awards where they're nominated for Duo of the Year.
Jordan Davis, who was the most played new artist of 2018, is up for New Male Artist of the Year.
The 54th Annual ACM Awards, hosted by Reba McEntire, will be broadcast live from the MGM Grand Garden Arena in Las Vegas April 7th at 8pm ET on CBS.
Audio / Chris Stapleton is going into this year's ACM Awards with six nominations, but one probably means the most to him.
Audio / Dierks Bentley talks about his ACM nominations for Male and Album, but he's also nominated for two other awards.
CARRIE UNDERWOOD'S "THE CHAMPION" FEATURING LUDACRIS CERTIFIED PLATINUM BY RIAA ON ANNIVERSARY OF 2018 SUPER BOWL DEBUT.
One year after garnering worldwide attention opening NBC's Super Bowl LII, Carrie Underwood's hit event anthem, "The Champion," featuring Ludacris, has been certified Platinum by the RIAA. Underwood co-wrote "The Champion" with fellow songwriters Brett James, Chris DeStefano, and Christopher Bridges PKA Ludacris, who Underwood asked to collaborate on the event song produced by Jim Jonsin. NBC Sports also incorporated "The Champion" into its coverage of the 2018 Olympic Winter Games.
Additionally, "The Champion" is featured as a bonus track on Underwood's critically-acclaimed, Gold-certified sixth studio album, Cry Pretty. Released in September 2018, Underwood's first studio album on Capitol Records Nashville, debuted at No. 1 on both the Billboard 200 and Top Country Album Charts and was the biggest all-genre debut by a female in 2018.
Co-produced by Underwood and writer/producer David Garcia, that debut earned Underwood a place in music history as the only woman to land four country albums at the top of the all-genre Billboard 200 chart, as well as the first female country act to top the Billboard Artist 100 Chart. The album was the best-selling Country album debut of 2018, as well as the biggest Country album debut since 2015 and the biggest female Country album debut since 2012. Cry Pretty's debut week also marked the most first week streams by any female in Country music. It is Underwood's seventh consecutive album to debut at No. 1 on the Top Country Albums chart, representing all of her first seven albums including her Greatest Hits: Decade #1. Underwood, who is nominated for Country Artist of the Year at the upcoming iHeartRadio Music Awards, was also Apple Music's most-streamed Country female artist for 2018. Cry Pretty debuted as the fifth most-streamed Country album in genre history and had the highest solo female debut for all music in 2018. It recently hit #1 again on the Country Album Charts in January, 2019.
The second single from the album, "Love Wins," continues to climb the charts.
The seven-time Grammy winner and Pollstar's three-time top female country touring artist will kick off a new arena tour, The Cry Pretty Tour 360, this Spring. Sponsored by CALIA, the tour will kick off on May 1 in Greensboro, NC, and will play 55 arenas across the U.S. and Canada and will be promoted by AEG Presents. She will be joined on tour by special guests Maddie & Tae and Runaway June.
Audio / CARRIE UNDERWOOD TALKS ABOUT WRITING "THE CHAMPION" FOR THE SUPER BOWL.
CARRIE UNDERWOOD WELCOMES NEW SON, JACOB BRYAN FISHER.
Carrie Underwood and husband Mike Fisher welcomed a bouncing baby boy – Jacob Bryan Fisher – on Monday (January 21st).
Carrie made the announcement on her socials on Wednesday (January 23rd), including photos of her holding Jacob; Mike holding his newborn son and big brother four-year-old Isaiah holding him, propped up by a big fluffy pillow.
Carrie, who's currently riding high on the country charts with "Love Wins," will get to spend some time with her newborn son and the rest of the family before she kicks off her Cry Pretty Tour 360 on May 1st in Greensboro, North Carolina.
KEITH, CARRIE DIERKS, DARIUS AND LITTLE BIG TOWN WILL CHANNEL THE KING DURING A NEW TELEVISION SPECIAL HONORING THE MUSIC OF ELVIS PRESLEY.
Keith Urban, Carrie Underwood, Dierks Bentley, Darius Rucker and Little Big Town will take part in NBC's Elvis All-Star Tribute airing February 17th at 9pm ET on NBC. The two-hour program, hosted by Blake Shelton, will tribute to Elvis Presley's "'68 Comeback Special," recreating the iconic night with musical performances, a showcase of rare footage and interviews with Priscilla Presley and Steve Binder, the director of the original special, plus a special appearance from Lisa Marie Presley.
The special will also include performances by Post Malone, Jennifer Lopez, Kelsea Ballerini, John Legend, Ed Sheeran, Shawn Mendes and many others. In addition to performing "Burning Love," Keith also teams up with Post Malone for "Baby, What You Want Me to Do." Dierks performs "Little Sister," while Little Big Town turns in "Are You Lonesome Tonight" and Darius sings "One Night." Check out the full list of musical performances below.


text:
Home Economy Feed the Rich Starve the Poor: Tory Budgets never change.
Feed the Rich Starve the Poor: Tory Budgets never change.
Greedy bankers
Banks are up the working poor are down.
Rishi Sunak has unveiled his Budget with the fanfare of a Chancellor with money to burn.
The chancellor painted a positive picture of the health of the UK economy as it emerges from the pandemic, in his autumn statement to a packed House of Commons.
He claimed he'll be pumping £150billion into the economy by 2025 as the UK recovers from the Covid pandemic.
It is distressing but not all that surprising to see the main priority for the former investment banker and hedge fund manager, Chancellor Sunak, was to feed the fat cats first. While the rest of humanity suffers, the fat cats, the financially robust, the lobbyists, the bankers, all have access to power to ensure that they will not only survive the crisis along with the economic downturn but thrive on it.
Looking after their own.
Sunak's decision to cut tax surcharges for bank profits by more than half in his Autumn Budget shows the 'levelling up' really means. It's little more than a continuation of feeding the rich while the rest are stuffed full of trickle-down theories and slogans of hard work pays.
Chancellor Sunak, a former investment banker and hedge fund manager, has cut the tax surcharge on bank profits in this week's Budget to help boost London's competitiveness as a global financial centre.
Sunak announce that the surcharge will be cut from 8% to 3% (a cut of 62.5%) from April 2023 when he announces the UK Government's spending plans on Wednesday, October 27.
It comes ahead of a hike in corporation tax from 19% to 25% in 2023, which Sunak had cautioned risks making "the taxation of banks uncompetitive".
Banks currently pay 27% tax on profits, of which 19% is corporation tax and 8% the bank surcharge.
They would see their overall corporation tax charge increase to 33% in 2023 if the surcharge was not reduced but the expected reduction would instead rise to 28%, an increase of just one percent.
The Treasury said it would also ensure the UK can continue to compete with other financial sectors including New York and Germany, where the effective tax rates for banks are 26% and 32% respectively.
Together, the surcharge cut and the allowance increase will cost the Treasury about £4bn in the five years to 2027, according to the Office for Budget Responsibility's forecasts on bank profitability.
Simon Youel, the head of policy and advocacy at campaign group Positive Money, said: "At a time when ordinary workers are facing a cost of living crisis, with cuts to universal credit, hikes to national insurance, and rising household bills, cutting taxes for bankers is a worrying sign of the government's priorities."
Of course, this will make British Banking much more competitive but that 'trickle down' has never worked before, we don't expect it to work any time soon.
The working poor see hard times.
The cut to taxes for banks comes less than a month after the UK cut Universal Credit for millions and as a hike in National Insurance payments set to be introduced. These are not cuts for the supposed 'Idle Poor' (if they ever existed) that usual demographic of Tory abuse, no, these are cuts to the overworked, overlooked, working poor, families struggling to make ends meet while facing massive price hikes at supermarkets and fuel stations.
These are the 2 million workers paid at or below the minimum wage, according to The Low Pay Commission.
Much of his Budget had been pre-announced, including an end to the public sector pay freeze and an increase to the National Living Wage from £8.91 per hour to £9.50.
The £2bn to Universal Credit announced on Wednesday will help ameliorate the pain from the withdrawal of the £20-a-week uplift – worth £6bn, there will be winners and losers with some of the poorest families in the UK worse off.
Universal Credit taper rate will be cut by 8% no later than 1 December, bringing it down from 63% to 55% – allowing claimants to keep more of the payment.
Paul Johnson, director of the Institute for Fiscal Studies, described the outlook for household finances as "actually awful".
But Paul Johnson told BBC News the "almost non-existent" increase in living standards predicted over the next five years was a "big blow" to families.
"The economy's not really growing very fast, so it's likely on average people's incomes will only be crawling over the next three, four even five years and certainly some people, particularly those whose wages don't go up as fast, will be feeling worse off. So this is not a period of people feeling better I'm afraid."
Mr Sunak, perhaps alive to that risk, did use this budget to inject the prospect of a more feel good taxation policies ahead of a general election by setting himself up for tax cuts just before the country goes back to the polls.
Household disposable income is set to rise by 0.8% per year, according to Office for Budget Responsibility figures.
Economic growth is forecast to rise to 6.3% next year – higher than previously predicted – but it will then slow to 1.3% by 2023.
The Office for Budget Responsibility forecasted inflation would peak at 4.4% in 2022 – but could climb to 5.4%.
That soaring inflation means higher goods and energy bill prices in the shops.
And it could lead to the Bank of England base rate – and therefore mortgage rates – being raised in a big way for the first time in more than a decade. Mr Sunak did not rule out this grim prospect.
The Chancellor's refusal to scrap the five percent VAT on energy amounts to an outright betrayal of Brexit voters, according to Mike Foster, CEO of the Energies and Utilities Alliance (EUA).
"I think it's a real letdown for consumers.
"They had been promised the cut back in the Brexit referendum and perhaps forgot about it until energy prices started to rocket.
"Suddenly, it becomes a far more pressing matter for consumers when they are seeing their energy bills rise by hundreds of pounds a year, and five percent of that going straight to the taxman even though the Prime Minister had made it very clear he was going to scrap that tax.
"And so there was an opportunity today to put the matter right but I think a lot of people will feel betrayed."
Class divide
Previous articleSir Keir Starmer tests positive for Covid missing both PMQs and the Budget
Next articleThe case of Julian Assange: If we tolerate this…
Governments have lost control the Oligarchy is winning
A Conversation with Bertrand Russell
MLK Day Special: Class Struggle and Dr Martin Luther King Jr.


text:
Q: python requests module: what's the difference between head and get request method when I use requests module to check whether a page is available.
for example:
>>> import requests
>>> url = "http://www.motie.com/book/29675"
>>> res = requests.head(url)
>>> print res.status_code
404
>>> res = requests.get(url)
>>> print res.status_code
200

I got status_code 404 and 200 for HEAD and GET respectively. I don't known why.
besides, how can I strace the reason. Thanks a lot.

A: The web server you contact is free to behave as it feels it should.  In this case it reports that it cannot find an answer for the head request even if it can find an answer for the get request.  This is not what it should do, but you would need to fix the server to solve this issue.
See some more about the head request here and of course in the WP here.
Actually, I think it is a bug in the server.


Our 2018-19 focus is to slow down and take a breath. No matter where you are on your faith journey, step back, take a breath, then take the next step.
Start your day with a small group of people delving into different topics.
Education time for ALL ages. No experience required.
A weekly podcast by the Easter pastors.
Easter's Adult Ministry and Encore Ministry offer a wide range of Learning opportunities. These change monthly. Some are on-going, some are one-time events.
Achieve your financial goals by learning to eliminate debt, save for the future, and give like never before.
2nd Tuesday of the month, 10:30 a.m.


Book your Room Online at HotelPuri Beach Resort in Puri by the Form Below. Here you can Reserve your Rooms and get the cheapest Rates for the Puri Beach Resort by selecting the best Possible Arrival dates and your Stay Schedule.
This affordable resort is within a few minutes' cab ride from the heart of Puri.The Puri Beach Resort provides a variety of premium services for guests, such as a currency exchange, a ticket service and 24 hours room service. It also offers a dry cleaning service, a laundry service and meeting rooms. Other features include a playground, luggage storage and laundry facilities.
The rooms at the Puri Beach Resort offer a TV, a refrigerator and cable / satellite channels. All rooms are air conditioned and equipped with a ceiling fan and an iron.The Puri Beach Resort has its own on-site restaurant, perfect for those who wish to eat in.The Puri Beach Resort conveniently offers free parking for guests travelling by car. Jagannath Temple Puri is also nearby.


On Monday our second puppy left us. Ian-Dino has become a real American now and in Lindsay and Christopher he has found some really kind and caring new parents. For now he will live in Italy near Naples.
Bye, bye, little Dino, we hope we hear from you.
Dino in the snow. Click on the photo and you see him in bigger size.
Ian-Dino has become a handsome male.
Der sieht ja niedlich aus!!


text:
Home Page > Football > Champions League > Manchester City vs Borussia Monchengladbach Betting Tips
Manchester City vs Borussia Monchengladbach Betting Tips
Etihad Stadium in Manchester will serve as the host for the match between Manchester City and Borussia Monchengladbach on 17th March 2021 at 01:30 IST. The odds are clearly in favor of Manchester City to win the match and qualify for the next phase. In the form that Monchengladbach are in, it is very unlikely that they will cut the two-goal deficit.
Manchester City are unbeaten in the Champions League as they bagged 16 points including five wins and one draw in the group stages and a comfortable 2-0 win in the first leg of the round of 16 against Monchengladbach. They were three points clear of the second-placed Porto at the top in group C. They have scored 15 goals and have conceded just one goal in the Champions League so far. They are ruling the English Premier League as of now as they have accumulated 71 points from 30 matches. They have won 22 matches, five draws and lost just three matches. They have scored as many as 64 goals and have conceded just 21 goals so far in the league. The youngster Ferran Torres has been in good form in the Champions League as he is the team's leading goal scorer with four goals. Kevin De Bruyne is the team's leading assist provider in both Premier League and the Champions League with 11 and four assists under his belt. Only Nathan Ake is doubtful for the round 16 clash as he is out with a muscle injury.
Monchengladbach finished in the second position in group B led by Real Madrid. M'gladbach had two wins, two draws and two losses in the Champions League group stages. They are coming into this fixture with a 2-0 loss in the first leg at home. Their Bundesliga journey is not going well as they are currently in tenth place with just 33 points from 25 matches. They have eight wins, nine draws and eight losses in the league so far. They have scored as many as 16 goals and have conceded 11 goals in the Champions League so far in seven matches. Alassane Plea is the team's leading goal scorer with five goals in the Champions League. But when it comes to the Bundesliga, their skipper Lars Stindl is the team's leading goal scorer with ten goals to his name. They have just three players who could miss the second leg round of 16 match, including Ramy Bensebaini, Famana Quizera and Christoph Kramer.
According to the Dafabet sportsbook, Manchester City are the favorites to win the match and are placed at 1.26, Monchengladbach are placed at 12.00 and the draw is at 6.40 odds. Manchester City are placed at 1.21 according to the 10Cric sportsbook, Monchengladbach are placed at 12.00 and the draw is at 6.45 odds. According to the Betway sportsbook, Manchester City are placed at 1.25, Monchengladbach are placed at 11.00 and the draw is at 6.00 odds.
Similar to the first leg, this is also going to be a low-scoring match. As the odds suggest Manchester City are in prime control of this round of 16 fixture as they are already up by two away goals.
Tip: Manchester City -1.5 @ 1.67
Manchester City are in some exceptional form as they have just lost one match in their last 30 matches in all competitions. Also, they have won 19 out of their last 20 matches in all competitions. In the last five head to head matches, Manchester City has won four matches and one match ended in a draw. Also, City have won three of the last five head to head matches by two or more goals. In three of the last five matches that City played in all competitions, City has won by more than two goals. In the last five home matches that Manchester City has played in all competitions, City has won by two or more goals in three matches. Apart from that, Monchengladbach is winless in the last eight matches and are also in a six-match losing streak. They are coming into this fixture with a two-goal loss to Augsburg away from home. So it is more likely that Manchester City will win the match by two or more goals at 1.67 odds available at the 10Cric sportsbook.
Tip: Total Goals Under 3.5 @ 1.67
In the last five head to head matches, under 3.5 goals were scored in three matches. Also, under 3.5 goals were scored in the first leg of this fixture as well. In five of the last seven matches that Manchester City has played in all competitions, under 3.5 goals were scored. Also, under 3.5 goals were scored in three of the last five home fixtures that Manchester City has played in all competitions. Monchengladbach has seen under 3.5 goals in eight of the last ten matches that they have played in all competitions. Apart from that, three of the last five away matches that Monchengladbach has played in all competitions had under 3.5 goals. So, it is more likely that this will be a low-scoring match with under 3.5 goals at 1.67 odds available at the Betway sportsbook.
The second leg looks like just a formality for Monchengladbach by considering their current form. But Manchester City are looking like they are not going to stop destroying teams. By looking at the current form and the team combination, Manchester City is more likely to make it to the next round.


Born on Jan. 3, 1945 in Yuma, Arizona, has gone home to be with his lord. He is joining his father, mother and brother; he passed away on Jubilee Sunday, April 29, 2018.
He is survived by his wife Judy Ann Langenegger of 32 years, their three children, and nine grandchildren and four great-grandchildren.